Online citations, reference lists, and bibliographies.
← Back to Search

Methionine Deprivation Regulates The Translation Of Functionally-distinct C-Myc Proteins.

S. Hann
Published 1995 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Numerous studies have demonstrated a critical role for the c-myc gene in the control of cellular growth. Alterations of the c-myc gene have been found associated with many different types of tumors in several species, including humans. The increased synthesis of one of the major forms of c-Myc protein, c-Myc 1, upon methionine deprivation provides a link between the regulation of oncogenes and the nutritional status of the cell. While deregulation or overexpression of the other major form, c-Myc 2, has been shown to cause tumorigenesis, the synthesis of c-Myc 1 protein is lost in many tumors. This suggests that the c-Myc 1 protein is necessary to keep the c-Myc 2 protein "in check" and prevent certain cells from becoming tumorigenic. Indeed, we have shown that overproduction of c-Myc 1 can inhibit cell growth. We have also shown that c-Myc 1 and 2 proteins have a differential molecular function in the regulation of transcription through a new binding site of Myc/Max heterodimers. We have also recently identified new translational forms of the c-Myc protein which we term delta-c-Myc. These proteins arise from translational initiation at downstream start sites which yield N-terminally-truncated c-Myc proteins. Since these proteins lack a significant portion of the transactivation domain of c-Myc, they behave as dominant-negative inhibitors of the full-length c-Myc 1 and 2 proteins. The synthesis of delta-c-Myc proteins is also regulated during cell growth and is repressed by methionine deprivation. Therefore, the synthesis of c-Myc 1 and delta-c-Myc proteins are reciprocally regulated by methionine availability. We have also found some tumor cell lines which synthesize high levels of the delta-c-Myc proteins. Taken together, our data suggest that c-Myc function is dependent on the levels of these different translational forms of c-Myc protein which are regulated by the nutritional status of the cell during growth. Numerous reports have demonstrated a fundamental and diverse role for the myc gene in cellular events, including proliferation, differentiation and apoptosis (Cole 1986; Spencer and Groudine 1991; Askew et al. 1991; Evan et al. 1992). This is dramatically illustrated by the frequent occurrence of a variety of tumors in many species having alterations of myc genes and the transduction of c-myc sequences by retroviruses (Spencer and Groudine 1991).4+ Eisenman 1990).(ABSTRACT TRUNCATED AT 400 WORDS)
This paper references
Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein.
E. Blackwood (1994)
Juxtaposition of domains homologous to protein kinases and histidyl-tRNA synthetases in GCN2 protein suggests a mechanism for coupling GCN4 expression to amino acid availability.
R. C. Wek (1989)
The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer.
P. D. Gregor (1990)
Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation.
H. Persson (1984)
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes
M. Kozak (1986)
The myc oncogene: its role in transformation and differentiation.
M. Cole (1986)
A quantitative model for translational control of the GCN4 gene of Saccharomyces cerevisiae.
J. P. Abastado (1991)
Control of c-myc regulation in normal and neoplastic cells.
C. Spencer (1991)
TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif.
H. Beckmann (1990)
Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems.
M. Kozak (1989)
Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein.
S. Maheswaran (1994)
TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.
G. Hateboer (1993)
Myc and Max proteins possess distinct transcriptional activities
L. Kretzner (1992)
Definition of regions in human c-myc that are involved in transformation and nuclear localization.
J. Stone (1987)
Chromatin structure of the HLA-DR alpha gene in different functional states of major histocompatibility complex class II gene expression.
B. Peterlin (1987)
An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
G. Kato (1990)
Mutations at a Zn(II) finger motif in the yeast elF-2β gene alter ribosomal start-site selection during the scanning process
T. F. Donahue (1988)
Translational activation of the non-AUG-initiated c-myc 1 protein at high cell densities due to methionine deprivation.
S. Hann (1992)
Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
A. Zervos (1993)
Alternative Forms of Max as Enhancers or Suppressors of Myc-Ras Cotransformation
Tomi P. M�kel� (1992)
Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
W. Gu (1993)
Human proto-oncogene N-myc encodes nuclear proteins that bind DNA.
G. Ramsay (1986)
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
S. Hann (1984)
Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region.
G. Prendergast (1991)
Translation initiation at non-AUG triplets in mammalian cells.
D. Peabody (1989)
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
D. Ayer (1993)
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Z. Cao (1991)
The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
S. Hann (1994)
Regulation of translation in eukaryotic systems.
M. Kozak (1992)
Coupling of GCN4 mRNA translational activation with decreased rates of polypeptide chain initiation
D. Tzamarias (1989)
Characterization of nuclear proteins that bind the EFII enhancer sequence in the Rous sarcoma virus long terminal repeat.
R. Sears (1992)
Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity.
Y. Hu (1990)
Reciprocal Regulation of Adipogenesis by Myc and C/EBPα
S. Freytag (1992)
Sequence-specific transcriptional activation by Myc and repression by Max.
C. Amin (1993)
A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas
S. Hann (1988)
Oncogenic conversion by regulatory changes in transcription factors
B. Lewin (1991)
Sequence-specific DNA binding by the c-Myc protein.
T. Blackwell (1990)
Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.
J. Bigler (1992)
Direct role for Myc in transcription initiation mediated by interactions with TFII-I
A. Roy (1993)
Mutations in the structural genes for eukaryotic initiation factors 2 alpha and 2 beta of Saccharomyces cerevisiae disrupt translational control of GCN4 mRNA.
N. P. Williams (1989)
At least two nuclear proteins bind specifically to the Rous sarcoma virus long terminal repeat enhancer.
L. Sealey (1987)
A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA
P. Descombes (1991)
More is better: Activators and repressors from the same gene
N. Foulkes (1992)
Oncogenic activity of the c-Myc protein requires dimerization with Max
B. Amati (1993)
A complex pattern of translational initiation and phosphorylation in L-myc proteins.
H. Dosaka‐Akita (1991)
Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc.
A. Shrivastava (1993)
Translational control in mammalian cells.
J. Hershey (1991)
A helix-loop-helix protein related to the immunoglobulin E box-binding proteins.
C. Carr (1990)
CCAAT-enhancer binding protein: a component of a differentiation switch.
R. M. Umek (1991)
New light on Myc and Myb. Part II. Myb.
B. Lüscher (1990)
Binding of myc proteins to canonical and noncanonical DNA sequences.
T. Blackwell (1993)
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
D. Askew (1991)
Ribosome association of GCN2 protein kinase, a translational activator of the GCN4 gene of Saccharomyces cerevisiae.
M. Ramirez (1991)
Induction of apoptosis in fibroblasts by c-myc protein
G. Evan (1992)
Binding and suppression of the Myc transcriptional activation domain by p107.
W. Gu (1994)
B-myc inhibits neoplastic transformation and transcriptional activation by c-myc.
L. Resar (1993)

This paper is referenced by
Independent and Associative Functions of IKKs and c-Myc in Cancer
Mamoona Noreen (2015)
Tracing MYC Expression for Small Molecule Discovery.
Jutta Steinberger (2019)
Human c-Myc Isoforms Differentially Regulate Cell Growth and Apoptosis in Drosophila melanogaster
C. Benassayag (2005)
Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.
R. Iyengar (2001)
independent of its translation . Exon 2-mediated c-myc mRNA decay in vivo
S. Pistoi (1996)
Myc inhibits JNK-mediated cell death in vivo
J. Huang (2016)
Expression of Caytaxin Protein in Cayman Ataxia Mouse Models Correlates with Phenotype Severity
K. M. Sikora (2012)
The interplay between MYCN and the DNA damage response : modulation of MYCN expression, its interactions with components of the DNA damage response and cellular responses to N-myc following genotoxic stress
A. Duarte (2012)
Expression Achieve Efficient c-MYC-or N-MYC-regulated Protein Use of a Modified Ornithine Decarboxylase Promoter to Updated Version
R. Iyengar (2001)
Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region
Y. He (2000)
Differentiation of lung cancer cell lines: a role for translational regulation of gene expression
D. Walsh (1999)
Characterization of Caytaxin Protein in Animal Models of Cerebellar Dysfunction.
Kristine M. Ito-Smith (2012)
Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11.
C. Pawlik (2000)
In silico analysis of SNPs in coding region of human c-Myc gene.
Mamoona Noreen (2015)
Characterisation of the Myc negative autoregulation mechanism
L. M. Facchini (1997)
Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.
K. Darcy (2009)
Function of the c-Myc oncogenic transcription factor.
C. V. Dang (1999)
Alternative transcription and alternative splicing in cancer.
S. Pal (2012)
Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells
M. Clemens (2000)
Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation.
S. Pistoi (1996)
Regulation of α7 Integrin Expression during Muscle Differentiation*
J. Xiao (2003)
Semantic Scholar Logo Some data provided by SemanticScholar